The US Food and Drug Administration has approved a landmark eye drop that uses a combined dose of medication to restore ...
The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive ...
The biotech also raised $235 million in debt and equity funding to support marketing of the drop, which it claims to be an ...
Dealbreaker on MSN
Presbyopia eye drop from startup Tenpoint gets FDA approval, paving way for $235M financing
Tenpoint Therapeutics’ Yuvezzi brings a combination approach to presbyopia compared to single mechanisms of action offered by once-daily eye drops from Orasis Pharmaceuticals, Lenz Therapeutics, and ...
YUVEZZI (TM) (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% is a dual-agent eye drop approved by the U.S. Food & Drug Administration (FDA) for the treatment of presbyopia, a ...
Tenpoint Therapeutics’ Yuvezzi gets US FDA nod; the first and only combo eye drop approved to treat presbyopia: London Saturday, January 31, 2026, 14:00 Hrs [IST] Tenpoint Thera ...
Repeat administration under compassionate use was previously shown to be well tolerated and associated with full corneal healing by 3 months as well as significant visual acuity improvement from hand ...
Credit: Alcon. Access initiatives including a First Fill Free trial program and an ongoing copay support will be available for eligible patients. The active ingredient in Tryptyr is acoltremon, an ...
(Gray News) - Several eye care products used to treat dry and irritated eyes are being voluntarily recalled. According to AvKARE, a pharmaceutical manufacturer, it has issued a recall following an ...
An optometrist shares why this seemingly harmless item can lead to bigger issues with your eye health.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results